skip to main content

New York State

These resources – like the public health crisis itself – are constantly evolving and are only current as to the date of publication. This page was last updated on July 20, 2020.

We recommend that you monitor this site, as well as the sites referenced in these resources, for updates and changes as we expect the situation and solutions to change over the coming weeks and months. For information on specific programs, we encourage you to visit the websites of the organizations or government entities that are responsible for the relief.

resource search icon

Description of Program and Relief

In Response to COVID-19, DFS Requires Insurance Companies to Waive Cost-Sharing for All In-Network Telehealth Visits

The New York State Department of Financial Services (DFS) announced a new emergency regulation requiring New York State insurance companies to waive cost-sharing, including deductibles, copayments (copays), or coinsurance for in-network telehealth visits. Insurance companies will waive co-pays for telehealth visits, whether or not related to COVID-19. This includes mental health care and substance use disorder treatment services. This new regulatory action helps encourage New Yorkers to seek medical attention from their homes rather than visit a hospital or doctor’s office for healthcare services, even those unrelated to COVID-19, ultimately reducing strain on the healthcare system and preventing further spread of COVID-19 or any other virus.

Government or Lead Agency

NYS Department of Financial Services

Dates Available

March 17, 2020 until terminated

Eligibility Requirements/Restrictions

All New Yorkers seeking in-network healthcare visits, whether or not related to COVID-19.

List of Additional Information

The DFS emergency regulation is available here:

https://www.dfs.ny.gov/industry_guidance/circular_letters/cl2020_06

A DFS press release with additional information is available here:

https://www.dfs.ny.gov/reports_and_publications/press_releases/pr20203171


© 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP. This does not constitute legal advice and does not create an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. Past representations are no guarantee of future outcomes.

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy